Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 4.830
+0.130 (2.77%)
At close: Mar 27, 2026
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 3.28 billion as of March 27, 2026. Its market cap has increased by 53.29% in one year.
Market Cap
3.28B
Enterprise Value
2.75B
Revenue
117.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.83
Market Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 3.28B, a decrease of -73.14%. That is a compound annual growth rate of -21.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.28B | 27.44% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 4.41B |
| Viva Biotech Holdings | 4.41B |
| Qyuns Therapeutics | 4.35B |
| Shandong Boan Biotechnology | 4.25B |
| TYK Medicines | 3.86B |
| Mirxes Holding Company | 3.71B |
| AIM Vaccine | 3.68B |
| Clover Biopharmaceuticals | 3.57B |